![Russell T. Kawahata](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Russell T. Kawahata
Nessuna posizione attualmente
Profilo
Dr. Russell T.
Kawahata is Vice President-Pharmaceutical Science at NeurogesX, Inc.
Dr. Kawahata was previously employed as Vice President-Technical Development & Operations by InterMune, Inc., General Manager by Soltec Research Pty Ltd., Senior Director-Product Innovation by Connetics Corp., a Director-Process Development by Systemix, Inc., and a Director-Process Development by XOMA Corp.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of California, Davis.
Precedenti posizioni note di Russell T. Kawahata
Società | Posizione | Fine |
---|---|---|
INTERMUNE INC | Corporate Officer/Principal | 01/01/2007 |
Stiefel Research Australia Pty Ltd.
![]() Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Corporate Officer/Principal | 01/01/2002 |
Connetics Corp.
![]() Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/01/2001 |
Systemix, Inc.
![]() Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | - |
XOMA CORPORATION | Corporate Officer/Principal | - |
Formazione di Russell T. Kawahata
University of California, Berkeley | Undergraduate Degree |
University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
XOMA CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
Systemix, Inc.
![]() Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Connetics Corp.
![]() Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Stiefel Research Australia Pty Ltd.
![]() Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
NeurogesX, Inc.
![]() NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
- Borsa valori
- Insiders
- Russell T. Kawahata